Sign In

News Story

September campaign asks men to Know Your Score

Prostate cancer is the most common cancer in men after skin cancer, with more men being diagnosed at later stages ─ making early detection more critical than ever. During Prostate Cancer Awareness Month this September, ACS is raising awareness about the importance of timely prostate cancer screening. Leading with a sports-focused message to “Know Your Score,” the integrated campaign seeks to motivate men to ask a doctor about prostate cancer screening. The core message for this year’s campaign is Know Your Score. Get Screened. Save Lives.

Former National Basketball Association (NBA) player and Basketball Hall of Famer Alonzo Mourning will be featured in this year’s campaign. Alonzo was diagnosed with stage III prostate cancer early in 2024. He had surgery in March 2024 and is now cancer free. He is determined to advocate for men to ask their provider about prostate cancer screening. Now, he’s advocating for men to learn their risk and get screened.

  • Cancer screening is for people without symptoms. Prostate cancer screening can help find cancer early, when it may be easier to treat.

  • The number of advanced stage prostate cancer diagnoses is increasing, after decades of decline.

  • At age 50, men at average risk should talk to a health care provider about prostate cancer screening. Men at increased risk of developing cancer should have that conversation earlier than age 50. Read the full prostate cancer screening guidelines

  • In 2025, an estimated 313,780 new cases of prostate cancer will be diagnosed in the US and 35,770 men will die from the disease.

  • Prostate cancer has the greatest mortality disparities of any cancer.

  • Black men have a higher risk of developing prostate cancer. They are also more likely to be diagnosed at an advanced stage and have a higher mortality rate compared to other racial and ethnic groups. There are also disparities among Native American men compared to White men. They have higher mortality despite lower incidence.

back to top